Latest news with #Antigen
Yahoo
28-06-2025
- Business
- Yahoo
Microsoft, Antigen Security Partner to Cut Cyber Insurance Costs
Microsoft Corporation (NASDAQ:MSFT) is one of the best software infrastructure stocks to invest in. On June 26, Antigen Security, LLC, announced a new partner program with Microsoft, establishing Antigen as one of Microsoft's Top 150 Managed Partners. The collaboration allows customers utilizing Microsoft 365 E3/E5 Security and Microsoft Azure Security to achieve an average of 20% to 60% savings on their cyber insurance premiums. These savings are realized when Microsoft's security suite is integrated into a risk-informed and standards-aligned cyber risk management strategy. The partnership uses Antigen's expertise in cyber liability insurance underwriting and claims research alongside Microsoft's advanced security products. Antigen's risk management approach adheres to industry-leading frameworks and ensures a coverage strategy that promotes 'Resilience by Design'. A development team working together to create the next version of Windows. As a Top 150 Managed Partner, Antigen will provide specialized training, marketing support, and incentives to various Microsoft channel partners. Antigen is also introducing 4 dedicated landing pages tailored for different audiences: New Microsoft Partners, Existing Microsoft Partners, New Microsoft Customers, and Existing Microsoft Customers. Microsoft Corporation (NASDAQ:MSFT) develops and supports software, services, devices, and solutions. While we acknowledge the potential of MSFT as an investment, we believe certain AI stocks offer greater upside potential and carry less downside risk. If you're looking for an extremely undervalued AI stock that also stands to benefit significantly from Trump-era tariffs and the onshoring trend, see our free report on the . READ NEXT: and . Disclosure: None. This article is originally published at Insider Monkey. Fehler beim Abrufen der Daten Melden Sie sich an, um Ihr Portfolio aufzurufen. Fehler beim Abrufen der Daten Fehler beim Abrufen der Daten Fehler beim Abrufen der Daten Fehler beim Abrufen der Daten
Yahoo
28-06-2025
- Business
- Yahoo
Microsoft, Antigen Security Partner to Cut Cyber Insurance Costs
Microsoft Corporation (NASDAQ:MSFT) is one of the best software infrastructure stocks to invest in. On June 26, Antigen Security, LLC, announced a new partner program with Microsoft, establishing Antigen as one of Microsoft's Top 150 Managed Partners. The collaboration allows customers utilizing Microsoft 365 E3/E5 Security and Microsoft Azure Security to achieve an average of 20% to 60% savings on their cyber insurance premiums. These savings are realized when Microsoft's security suite is integrated into a risk-informed and standards-aligned cyber risk management strategy. The partnership uses Antigen's expertise in cyber liability insurance underwriting and claims research alongside Microsoft's advanced security products. Antigen's risk management approach adheres to industry-leading frameworks and ensures a coverage strategy that promotes 'Resilience by Design'. A development team working together to create the next version of Windows. As a Top 150 Managed Partner, Antigen will provide specialized training, marketing support, and incentives to various Microsoft channel partners. Antigen is also introducing 4 dedicated landing pages tailored for different audiences: New Microsoft Partners, Existing Microsoft Partners, New Microsoft Customers, and Existing Microsoft Customers. Microsoft Corporation (NASDAQ:MSFT) develops and supports software, services, devices, and solutions. While we acknowledge the potential of MSFT as an investment, we believe certain AI stocks offer greater upside potential and carry less downside risk. If you're looking for an extremely undervalued AI stock that also stands to benefit significantly from Trump-era tariffs and the onshoring trend, see our free report on the . READ NEXT: and . Disclosure: None. This article is originally published at Insider Monkey. Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
Time of India
28-05-2025
- Health
- Time of India
Arunachal Pradesh reports first Covid-19 case of current wave
NEW DELHI: Arunachal Pradesh reported its first Covid-19 case of the current wave as a mother-daughter duo tested positive through RT-PCR on Tuesday, confirmed state surveillance officer Lobsang Jampa. Tired of too many ads? go ad free now The cases were detected in Itanagar when a 34-year-old pregnant woman and her 53-year-old mother tested positive. The pregnant woman initially tested positive through a Rapid Antigen Test on Monday after experiencing fever and mild cough. She had traveled to Itanagar from Bengaluru on May 13. "We conducted the RT-PCR test on Tuesday to confirm the infection, and it came back positive," Jampa said. The woman's mother also tested positive but remains asymptomatic. While the pregnant woman is receiving hospital treatment, her mother has been placed in isolation. "The health department is closely monitoring the situation and taking all necessary precautions to prevent further spread of the virus," Jampa stated. Jampa urged the public not to panic, noting that the new strain is not as severe as previous variants. Health officials will soon release a detailed public health advisory after consulting with the National Centre for Disease Control in Delhi.
Time of India
20-05-2025
- Health
- Time of India
Breaking the silence on prostate cancer: From early signs to life-saving screening
Prostate cancer is the second most common cancer and the sixth leading cancer that causes death among men, worldwide. In 2020, there were an estimated 1.4 million new prostate cancer cases, causing 3,75,000 deaths. Nine among 1, 00,00 men have prostate cancer in India, which shows an increasing trend every year. Prostate cancer cases are rising at an alarming rate in the country. This cancer begins in the gland cells of the prostate .The prostate is located just below the bladder, is the size of a walnut, and surrounds the urethra. The risk factors for this cancer are age, genetics, and diet, a diet high in fats and meat, smoking, and obesity are all linked to prostate cancer. The symptoms are frequent urination, blood in the urine and semen, burning sensation while urination. Hence, timely screening for prostate cancer will help to improve patient outcomes. Understanding the screening for prostate cancer: Prostate cancer is screened using tests such as Prostate Specific Antigen (PSA) Test and Digital Rectal Examination (DRE). A prostate-specific Antigen (PSA) test is carried out to examine the level in the blood. Prostate cancer screening should be done as per the urologist's advice. A digital rectal exam (DRE), is a medical test that helps to look for abnormalities in your rectum, anus, and prostate gland. Other vital tests are biopsy, transrectal ultrasound (TRUS), magnetic resonance imaging (MRI), bone scan, and PET scan. The treatment: This cancer involves radical prostatectomy which is done to remove the prostate gland and its surrounding glands to manage it. Apart from this, the patient will be advised radiation therapy, chemotherapy, or even hormonal therapy. Timely detection of prostate cancer is the need of the hour: Go for regular health check-ups and follow-ups as advised by the expert. It is necessary to take charge of prostate health without any further delay just like you take care of your heart and respiratory health. Moreover, one should adopt preventive measures such as a healthy diet, exercising regularly, and quitting smoking and alcohol. Do PSA and DRE yearly after the age of 50 or early if family history is positive. Important thing to note is to consult a urologist before coming to any conclusion and follow up for the urinary complaints. Dr Vikas Bhise, Consultant Urologist and Transplant Surgeon, Medicover Hospitals, Navi Mumbai One step to a healthier you—join Times Health+ Yoga and feel the change
